SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda
Athletes subject to anti-doping rules should treat the blend as prohibited on that basis
Site rotation strategy is crucial for preventing lipohypertrophy (tissue thickening), lipoatrophy (tissue thinning), and localized skin reactions
2007 Nov-Dec;35(6):900-8
The GIP component enhances fat tissue function and further supports appetite control